Navigation Links
Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface
Date:8/19/2009

LAWRENCEVILLE, N.J., Aug. 19 /PRNewswire/ -- Aton Pharma, Inc. announced today that The Ocular Surface, a leading peer-reviewed ophthalmology journal, has published an article that includes results of a retrospective case series study of dry eye patients using Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert). The article, "Extending the Duration of Tear Film Protection: Review and Retrospective Case Series Study of the Hydroxypropyl Cellulose Ophthalmic Insert," by Arden H. Wander, M.D. and Bruce H. Koffler, M.D., discusses how the duration of tear film protection in dry eye patients can be extended using artificial tear formulations with enhanced viscosity/polymeric systems, the hydroxypropyl cellulose insert and other approaches.

Lacrisert is a preservative-free, once-daily*, sustained release prescription insert indicated for moderate to severe dry eye, that helps to retain moisture, stabilize the tear film, and lubricate the eye.

"Our retrospective case series indicates that the hydroxypropyl cellulose ophthalmic insert can be a valuable treatment for dry eye patients, either alone or in conjunction with other therapies," concluded Dr. Koffler. "The reports of symptom improvement and extremely low rate (2.5%) of adverse effects suggest that the inserts are an appropriate long-term therapy. The fact that so many patients had been using the inserts for more than 5 years suggests that it is a relatively safe, tolerable, and effective therapy."

"This is the first peer-review publication for Lacrisert in more than two decades," stated Michael G. Wells, Chief Executive Officer of Aton Pharma. "Pursuing scientific and clinical publications is part of our commitment to contributing to physician knowledge of Lacrisert."

Recently, results of a large (n = 520) multi-center patient registry study of the Lacrisert insert were presented during
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... today announced that executives of the company will address ... Sachs CEO Unplugged Conference on Jan. 6 at ... New York. 28th Annual J.P. Morgan Healthcare ... the Westin St. Francis Hotel in San Francisco. ... Health,s diverse products and services, company performance and strategies ...
(Date:12/14/2009)... Dec. 14 Greenway Medical ... integrated EHR, Prime Suite (®) ... 2011 Ambulatory EHR, additionally certified for Child ... Reporting. Greenway,s Prime Suite 2011 achieved ... certification designations offered by the Certification Commission ...
(Date:12/14/2009)... -- Cardium Therapeutics (NYSE Amex: CXM ) ... GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," ... Industry Conference held December 10-13, 2009 in St. ... attended by top industry leaders and renowned researchers ... Dr. Barbara K. Sosnowski, Cardium,s Vice President of ...
Breaking Medicine Technology:Cardinal Health Executives to Speak at Two Investor Events in January 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4Scientists discover gene module underlying atherosclerosis development 10995 1Scientists discover gene module underlying atherosclerosis development 10995 2How nutrition affects healthy aging 10992 1How nutrition affects healthy aging 10992 2Miami Dentist Dr H A Nassery Treats Local Teen Golf Star and Helps Improve Her Performance 62601 1Miami Dentist Dr H A Nassery Treats Local Teen Golf Star and Helps Improve Her Performance 62601 2
... than 70 abstracts highlight VELCADE efficacy in broad ... CAMBRIDGE, Mass., June 19, 2007 /PRNewswire-FirstCall/ --,Millennium Pharmaceuticals, ... leading therapy with unsurpassed single-agent,efficacy for patients with ... the upcoming International Myeloma,Workshop (IMW) in Kos, Greece, ...
... Describes Identification, Characterization and Broad,Neuroprotective Properties of ... , Neurodegenerative Disease Specialists Publish Details of ... Mitochondrial Proteins , MARSEILLE, June 19th, 2007 ... the discovery and development of drugs for,neurological ...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 2Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 3Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 4
(Date:12/14/2009)... Realty Trust ("Americold") announced today that it has filed ... Securities and Exchange Commission (the "SEC") relating to a ... number of shares to be offered and the price ... The common shares to be sold in this offering ... The joint book-running managers of the offering will be ...
(Date:12/14/2009)... Aflac Incorporated announced today that it has priced ... with a coupon of 6.9%. The notes will ... yield 6.984%. The company anticipates using the proceeds ... corporate purposes. ,, Commenting on the pricing of ... Financial Officer Kriss Cloninger III commented: "This debt ...
(Date:12/14/2009)... 14 Tough Enough To Wear Pink(TM) (TETWP), ... celebrated its fifth anniversary at the signature Tough ... National Finals Rodeo (Wrangler NFR) in Las Vegas. ... rodeo cowboys, the support of the western industry ... crowd sported pink shirts, hats, bracelets and more. ...
(Date:12/14/2009)... government controlled health care, before moving to the U.S. to practice ... his new book, Health Reform: The End of the American Revolution?, ... its threat to real health care! , ... (PRWEB) ... from Minnesota, warns Americans not to sell out their liberty for ...
(Date:12/14/2009)... COLUMBUS, Ohio, Dec. 14 Skilled nursing facilities ... and services in order to deal with a 92 ... permit fee) from $6.25 to $12.01 per bed per ... that the average facility will pay an additional $17,520 ... for a total tax of $438,365 yearly. ,, Nearly ...
Breaking Medicine News(10 mins):Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3
... A study led by a team of education researchers ... Journal of the American Medical Association ( ... , Lead author David Cook, M.D., an associate professor ... Clinic, worked with researchers from Mayo and McMaster University ...
... systems, MIT study suggests , , THURSDAY, Sept. 11 (HealthDay News) ... believe your eyes. , A team of neuroscientists publishing ... said they have tricked the brain into confusing one object ... for humans to learn to recognize objects. , People never ...
... , ... Bethesda, MD (Vocus) September 11, 2008 -- ... for many teams in the spotlight have evolved from the typical ... starting running back for the Ohio State University Buckeyes, continues to ...
... Lets Nursing Home Resident Participate in Activities,and Enjoy Day ... and crafts,table at the Heartland of Columbia Nursing Home ... power wheelchair from The SCOOTER Store, Pam,Lewis, 47, is ... mobility., Heartland,s activities director, David Moreland, knew Ms. ...
... (NYSE:,NTY) (http://www.NBTY.com ), a leading global manufacturer and ... cast the,presentation by Harvey Kamil, President and Chief Financial ... in New York on Wednesday,September 17, 2008., The ... NBTY,s web site, (http://www.nbty.com ) on Wednesday, September 17, ...
... IM) announced,today the sale of their flagship product, ... The Johns Hopkins Hospital in Baltimore,Maryland., IMRISneuro ... IMRIS,one-of-a kind, movable high field MRI. The new ... operating room during brain surgery,helping to rule out ...
Other Medicine News:Health News:Internet-based instruction effective for teaching health-care professionals 2Health News:Time Teaches Brain to Recognize Objects 2Health News:Foot Injuries Plague Athletes During Fall Sports Season 2Health News:Foot Injuries Plague Athletes During Fall Sports Season 3Health News:The SCOOTER Store's Gift of a Power Wheelchair Allows Woman to Enjoy Active Life Once Again 2Health News:NBTY to Web Cast Presentation at CL King Best Ideas Conference 2
... the right viscoelastic agent for the surgeon ... extracap technique. Amvisc possesses sufficient viscosity for ... is highly cohesive so that complete removal ... easily and quickly accomplished. Amvisc is priced ...
... to provide excellent protection and ease of ... being closer to an adhesive in molecular ... CoEase to maintain viscosity at high shear ... worlds for superb performance during capsulorhexis, phaco, ...
... DUOVISC Viscoelastic System is designed to ... properties that can be used differently and ... cataract procedure. The choice of the viscoelastic ... differential ability of each to facilitate performance ...
... is used to plan precisely for the ... the surgeon can simulate the surgery using ... This enables the selection of an optimal ... and procedural costs. The surgeon can review ...
Medicine Products: